# A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine

> **NCT04179071** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16 (actual)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** Savolitinib
- **DRUG:** Famotidine

## Key facts

- **NCT ID:** NCT04179071
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-13
- **Primary completion:** 2020-03-11
- **Final completion:** 2020-03-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179071, "A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04179071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*